RARA CRAFT DATABASE for FDA Medical Devices
510(k)K260256

FDA DEVICE FACTS

Q-Switched Nd: YAG Laser Systems

Shanghai Apolo Medical Technology Co., Ltd.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEMay 4, 2026PRODUCT CODEGEXCLINICAL AREASurgery

Indications for use

The Q-Switched Nd: YAG Laser System is intended for use in tattoo removal, treatment of benign vascular lesions, treatment of benign pigmented lesions, incision, excision, ablation, vaporization of soft tissue for general dermatology as follows: 532nm in nanosecond mode, including microbeam handpieces (nominal delivered energy of 585nm and 650nm with optional dye handpieces): -Removal of light ink (red, sky blue, green, purple, and orange) tattoo, -Treatment of benign vascular lesions including, but not limited to: telangiectasias, -Treatment of benign epidermal pigmented lesions including, but not limited to: cafe-au-lait, solar lentiginos, senile lentiginos, Becher's, nevi Freckles, Nevus spilus, Seborrheic Keratoses, -Treatment of Post Inflammatory Hyper-Pigmentation,

- Skin resurfacing procedures for the treatment of acne scars and wrinkles. 1064nm in nanosecond mode (with QS, Q-PTP, Q-3, Q-4 function), including microbeam handpieces: -Removal dark ink (black, blue and brown) tattoo, -Removal of benign dermal pigmented lesions including, but not limited to: Nevus of OTA, Common Nevi, and Melasma, -Removal or lightening of unwanted hair with or without adjuvant preparation, -Skin resurfacing procedures for the treatment of acne scars and wrinkles. 1064nm in SPT mode: -Treatment of wrinkles, -Treatment of mild to moderate inflammatory acne vulgaris. 1064nm in LPS (Long pulse) mode: -Removal of unwanted hair, for stable long term or permanent hair reduction and treatment of PFB. The lasers are indicated on all skin types Fitzpatrick I-VI including tanned skin, -Photocoagulation and hemostasis of pigmented and vascular lesions, such as but not limited to port wine stains, hemangiomas, warts, telangiectasias, rosacea, leg veins, and spider veins, -Coagulation and hemostasis of soft tissue, -Treatment of wrinkles and acne vulgaris.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: July 28, 2026